As of Mar 22
| -1.36 / -2.37%|
The 23 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 74.00, with a high estimate of 95.00 and a low estimate of 62.00. The median estimate represents a +32.05% increase from the last price of 56.04.
The current consensus among 25 polled investment analysts is to Buy stock in CVS Health Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.